Clinical Trials Browser

Phase 2 × Adenocarcinoma Of Esophagus × Sunitinib × Clear all

NCT00891878 2018-07-24

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Phase 2 Completed

12 enrolled 12 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms